Anthony Dobranowski

Director/Board Member presso NUVO PHARMACEUTICALS INC.

Patrimonio netto: 31 500 $ in data 30/04/2024

Producer Manufacturing

Health Technology

Miscellaneous

Posizioni attive di Anthony Dobranowski

Società	Posizione	Inizio	Fine
NUVO PHARMACEUTICALS INC.	Director/Board Member	21/09/2004	-
NUVO PHARMACEUTICALS INC.	Independent Dir/Board Member	13/12/2011	-
CRESCITA THERAPEUTICS INC.	Director/Board Member	01/03/2016	-
CRESCITA THERAPEUTICS INC.	Independent Dir/Board Member	01/03/2016	-

Società	Posizione	Inizio	Fine
MAGNA INTERNATIONAL INC.	Corporate Officer/Principal	01/01/2005	01/09/2007
Tesma International, Inc. Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada	Director/Board Member	01/01/1995	-
	Director of Finance/CFO	01/01/1995	-
	President	01/01/1995	-
Heating Oil Partners Income Fund	Director/Board Member	-	-

University of Toronto

Masters Business Admin

Distribuzione geografica

Canada

Posizioni

Director/Board Member	4
Independent Dir/Board Member	2
Masters Business Admin	1

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
MAGNA INTERNATIONAL INC.	Producer Manufacturing
CRESCITA THERAPEUTICS INC.	Health Technology

Aziende private	3
Tesma International, Inc. Tesma International, Inc. Auto Parts: OEMProducer Manufacturing Tesma International, Inc. is used to manufacture engine, transmission and fueling components. Its engine productsuesd to include oil and water pumps, as well as pulleys and tensioners. Its transmission systems uesd to include torque converters and clutch housings. Its offerings uesd to include cap-to-tank refueling modules. It was located in Concord, Canada	Producer Manufacturing
Nuvo Pharmaceuticals, Inc. Nuvo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Nuvo Pharmaceuticals, Inc. is a pharmaceutical company, which is engaged in developing innovative therapeutic pharmaceutical products. It operates through the following segments: Commercial Business, Production and Service Business, and Licensing and Royalty Business. The Commercial Business segment includes Blexten, Cambia, the canadian business for Resultz and Suvexx, and mature assets. The Production and Service Business segment supplies Pennsaid to Horizon for the U.S. market and is engaged in ongoing partnering efforts for Pennsaid. The Licensing and Royalty Business segment engages in the selling of Vimovo. The company was founded on August 22, 1983 and is headquartered in Mississauga, Canada.	Health Technology
Heating Oil Partners Income Fund	Miscellaneous